Chracteristic | Treatment successc | Treatment failure | Total | Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|---|---|---|---|
Cure, TC n(%) | Failure (n,%) | N (%) | OR (95% CI)d | P | OR (95% CI) | P | ||||
Sex | ||||||||||
Male | 105 | 54.69 | 42 | 21.88 | 192 | 73.28 | 1.25(0.656–2.383) | 0.498 | 0.66(0.109–4.011) | 0.652 |
Female | 40 | 57.14 | 20 | 28.57 | 70 | 26.72 | 1 | 1 | ||
Age | ||||||||||
< 60 year | 124 | 62.94 | 35 | 17.77 | 197 | 75.19 | 4.555(2.302–9.015) | 0.000 | 9.053(1.606–51.027) | 0.013 |
≥ 60 year | 21 | 32.31 | 27 | 41.54 | 65 | 24.81 | 1 | 1 | ||
Occupationa | ||||||||||
Farmer | 108 | 54.82 | 47 | 23.86 | 197 | 75.19 | 0.932(0.467–1.859) | 0.841 | 1.343(0.262–6.898) | 0.724 |
Others | 37 | 56.92 | 15 | 23.08 | 65 | 24.81 | 1 | 1 | ||
Family registerb | ||||||||||
Resident | 62 | 50 | 38 | 30.65 | 124 | 47.33 | 0.472(0.257–0.866) | 0.015 | 5.502(0.778–38.935) | 0.088 |
Floating | 83 | 60.14 | 24 | 17.39 | 138 | 52.67 | 1 | 1 | ||
Previous TB treatment | ||||||||||
No | 14 | 66.67 | 4 | 19.05 | 21 | 8.02 | 1.55(0.489–4.911) | 0.457 | 2.033(0.113–36.662) | 0.631 |
Yes | 131 | 54.36 | 58 | 24.07 | 241 | 91.98 | 1 | 1 | ||
Weight | ||||||||||
< 50 kg | 19 | 44.19 | 16 | 37.21 | 43 | 16.41 | 2.824(1.198–6.657) | 0.018 | 8.668(1.679–44.756) | 0.01 |
> = 50 kg | 57 | 64.04 | 17 | 19.1 | 89 | 33.97 | 1 | 1 | ||
TB symptoms | ||||||||||
Hemoptysis | ||||||||||
Yes | 105 | 58.01 | 38 | 20.99 | 181 | 69.08 | 0.603(0.322–1.129) | 0.114 | 8.928(1.048–76.923) | 0.045 |
No | 40 | 49.38 | 24 | 29.63 | 81 | 30.92 | 1 | 1 | ||
Cavitary | ||||||||||
Yes | 42 | 33.07 | 42 | 33.07 | 127 | 48.47 | 5.154(2.71–9.803) | 0.000 | 10.204(2.032–52.631) | 0.005 |
No | 103 | 76.3 | 20 | 14.81 | 135 | 51.53 | 1 | 1 | ||
Treatment | ||||||||||
Standard treatment | 136 | 57.87 | 53 | 22.55 | 235 | 89.69 | 2.566(0.966–6.816) | 0.059 | 0.447(0.027–7.449) | 0.575 |
Individualized treatment | 9 | 33.33 | 9 | 33.33 | 27 | 10.31 | 1 | 1 | ||
Hosipitalization | ||||||||||
No | 115 | 58.67 | 41 | 20.92 | 196 | 74.81 | 0.509(0.263–0.987) | 0.046 | 0.365(0.066–2.009) | 0.247 |
Yes | 30 | 45.45 | 21 | 31.82 | 66 | 25.19 | 1 | 1 | ||
Liver protection drugs | ||||||||||
Yes | 38 | 48.72 | 24 | 30.77 | 78 | 29.77 | 1.779(0.946–3.344) | 0.074 | 1.764(0.935–142.857) | 0.056 |
NO | 107 | 58.15 | 38 | 20.65 | 184 | 70.23 | 1 | 1 | ||
First-line oral anti-TB agents | ||||||||||
Ethambutol | ||||||||||
R | 58 | 54.21 | 25 | 23.36 | 107 | 40.84 | 0.987(0.538–1.81) | 0.965 | 1.721(0.37–8.009) | 0.489 |
S | 87 | 56.13 | 37 | 23.87 | 155 | 59.16 | 1 | 1 | ||
Injectable anti-TB agents | ||||||||||
Streptomycin | ||||||||||
R | 92 | 57.5 | 34 | 21.25 | 160 | 61.07 | 1.43(0.782–2.614) | 0.246 | 1.85(0.46–7.451) | 0.387 |
S | 53 | 51.96 | 28 | 27.45 | 102 | 38.93 | 1 | 1 | ||
Kanamycin | ||||||||||
R | 7 | 36.84 | 9 | 47.37 | 19 | 7.25 | 0.299(0.106–0.843) | 0.022 | 0.137(0.005–3.663) | 0.236 |
S | 138 | 56.79 | 53 | 21.81 | 243 | 92.75 | 1 | 1 | ||
Fluoroquinolones | ||||||||||
Ofloxacin | ||||||||||
R | 14 | 35.9 | 14 | 35.9 | 39 | 14.89 | 0.366(0.163–0.825) | 0.015 | 0.793(0.101–6.209) | 0.825 |
S | 131 | 58.74 | 48 | 21.52 | 223 | 85.11 | 1 | 1 | ||
Treatment regularity | ||||||||||
No | 2 | 7.14 | 18 | 64.29 | 28 | 10.69 | 29.411(6.535–125) | 0.000 | 47.619(5.025–500) | 0.001 |
Yes | 143 | 61.11 | 44 | 18.8 | 234 | 89.31 | 1 | 1 | ||
Resistant patterne | ||||||||||
R/H | 38 | 52.05 | 21 | 28.77 | 73 | 27.86 | 0.693(0.364–1.319) | |||
R/H/E | 13 | 61.90 | 4 | 19.05 | 21 | 8.02 | 1.428(0.447–4.566) | |||
R/H/S | 42 | 66.67 | 11 | 17.46 | 63 | 24.05 | 1.891(0.899–3.978) | |||
R/H/S/E | 37 | 56.92 | 12 | 18.46 | 65 | 24.81 | 1.427(0.686–2.969) | |||
R/H/Ofx/Km/S/E | 3 | 30.00 | 6 | 60.00 | 10 | 3.82 | 0.131(0.026–0.666) | 0.014 |